Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

In hepatocellular carcinoma, which factor most strongly influences prognosis?

In hepatocellular carcinoma, prognosis is driven most by how advanced the tumor is together with how well the liver is functioning. The liver often carries underlying cirrhosis, so liver reserve determines both how well a patient tolerates treatment and how likely liver failure is as the disease progresses. A patient with a small tumor but severely impaired liver function may have worse survival than someone with a larger tumor but preserved liver function, because the liver’s capacity to support life and recover after treatment is a key limiting factor. That's why tumor stage and liver function are the strongest prognostic factors. Staging captures tumor size, number, vascular invasion, and spread, all of which directly relate to survival, while liver function (often assessed by Child-Pugh class or related measures) reflects the remaining hepatic reserve and treatment tolerance. Together, they provide a more accurate forecast than age, a single tumor size, or unrelated lab values like cholesterol. In practice, staging systems like BCLC integrate these elements to estimate prognosis and guide decisions.

In hepatocellular carcinoma, prognosis is driven most by how advanced the tumor is together with how well the liver is functioning. The liver often carries underlying cirrhosis, so liver reserve determines both how well a patient tolerates treatment and how likely liver failure is as the disease progresses. A patient with a small tumor but severely impaired liver function may have worse survival than someone with a larger tumor but preserved liver function, because the liver’s capacity to support life and recover after treatment is a key limiting factor.

That's why tumor stage and liver function are the strongest prognostic factors. Staging captures tumor size, number, vascular invasion, and spread, all of which directly relate to survival, while liver function (often assessed by Child-Pugh class or related measures) reflects the remaining hepatic reserve and treatment tolerance. Together, they provide a more accurate forecast than age, a single tumor size, or unrelated lab values like cholesterol.

In practice, staging systems like BCLC integrate these elements to estimate prognosis and guide decisions.